Featured Research

from universities, journals, and other organizations

Treatment outcomes for infantile hemangiomas compared

Date:
July 19, 2010
Source:
Medical College of Wisconsin
Summary:
In an ongoing effort to find better and safer treatment for complicated infantile hemangiomas, researchers report outcomes on two treatment options. The first study examined the effects of oral steroids on a group of patients and the second highlights possible complication/side effect from propranolol, a novel therapy for hemangioma. Both studies will facilitate safer therapy.

In an ongoing effort to find better and safer treatment for complicated infantile hemangiomas, researchers at The Medical College of Wisconsin and Children's Hospital of Wisconsin, report outcomes on two treatment options. The first study examined the effects of oral steroids on a group of patients and the second highlights possible complication/side effect from propranolol, a novel therapy for hemangioma.

Both studies published in the Archives of Dermatology, will facilitate safer therapy.

Infantile hemangiomas are benign tumors composed of blood vessel-like cells that grow in the first month of life. The duration and rate of growth is variable; some infants will have hemangiomas that grow very little while others grow at an alarming rate. Approximately 80,000 children annually are diagnosed with hemangiomas in the United States; 12 percent or 9,600 of those are significantly complex, requiring referral to specialists for consideration of treatment. Complications of hemangiomas include permanent disfigurement, ulceration, bleeding, loss of vision, airway obstruction, congestive heart failure and very rarely death.

"Despite the increasing incidence and the severity of potential complications, we lack uniform treatment guidelines for the treatment and response to treatment of infants with hemangiomas. There are no FDA-approved agents for the treatment of hemangiomas, thus physicians must rely on observational reports and clinical judgment to determine optimal treatment of infants with complicated hemangiomas," points out Beth A. Drolet, M.D., senior author on both studies. Dr. Drolet is medical director, Dermatology, Birthmarks and Vascular Anomalies Center, Children's Hospital, and professor and vice chairman of dermatology and professor pediatrics; and chief of pediatric dermatology at the Medical College.

There are no management guidelines or safety data on large groups of infants treated with these medications for infantile hemangioma as the safety of many of the existing therapies have not been studied in a scientific fashion. Medications with reported efficacy include corticosteroids, the mainstay of therapy, and more recently propranolol which is viewed as a safer alternative to traditional therapy.

To address this lack of data, the first study looked at 16 infants at Children's Hospital with a mean age of 2.9 months, who were treated with corticosteroids for complicated hemangiomas. Over a period of 22 weeks, the researchers found profound, but reversible, suppression of the immune system. Other side effects included hypertension, sleep disturbance and weight gain.

The second publication describes three patients treated with oral propranolol who developed severe and symptomatic hypoglycemia during treatment, a condition in which the blood sugar is very low and can result in lethargy, confusion, and even seizures in these infants. The researchers also reviewed the literature to identify other reports of propranolol-associated hypoglycemia in children to highlight this rare side effect.

According to Dr. Drolet, "Given the lack of evidence-based standards for treatment of complicated infantile hemangiomas combined with the risks of accepted systemic therapies, care givers need to be aware of these side effects. We are committed to performing high quality studies to scientifically determine which therapies are more effective and to insure that these interventions are safe in these young babies"

Michael E. Kelly, M.D., Ph.D., assistant professor of pediatrics -- hematology/oncology, is the first author on the corticosteroids study and Kristen E. Holland, M.D., assistant professor of dermatology, is the first author on the propranolol study.


Story Source:

The above story is based on materials provided by Medical College of Wisconsin. Note: Materials may be edited for content and length.


Journal References:

  1. Michael E. Kelly; Anna M. Juern; William J. Grossman; Dennis W. Schauer; Beth A. Drolet. Immunosuppressive Effects in Infants Treated With Corticosteroids for Infantile Hemangiomas. Archives of Dermatology, 2010;
  2. Kristen E. Holland; Ilona J. Frieden; Peter C. Frommelt; Anthony J. Mancini; David Wyatt; Beth A. Drolet. Hypoglycemia in Children Taking Propranolol for the Treatment of Infantile Hemangioma. Archives of Dermatology, 2010;

Cite This Page:

Medical College of Wisconsin. "Treatment outcomes for infantile hemangiomas compared." ScienceDaily. ScienceDaily, 19 July 2010. <www.sciencedaily.com/releases/2010/07/100719163946.htm>.
Medical College of Wisconsin. (2010, July 19). Treatment outcomes for infantile hemangiomas compared. ScienceDaily. Retrieved April 17, 2014 from www.sciencedaily.com/releases/2010/07/100719163946.htm
Medical College of Wisconsin. "Treatment outcomes for infantile hemangiomas compared." ScienceDaily. www.sciencedaily.com/releases/2010/07/100719163946.htm (accessed April 17, 2014).

Share This



More Health & Medicine News

Thursday, April 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com
Thousands Of Vials Of SARS Virus Go Missing

Thousands Of Vials Of SARS Virus Go Missing

Newsy (Apr. 16, 2014) A research institute in Paris somehow misplaced more than 2,000 vials of the deadly SARS virus. Video provided by Newsy
Powered by NewsLook.com
Formerly Conjoined Twins Released From Dallas Hospital

Formerly Conjoined Twins Released From Dallas Hospital

Newsy (Apr. 16, 2014) Conjoined twins Emmett and Owen Ezell were separated by doctors in August. Now, nearly nine months later, they're being released from the hospital. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins